首页> 美国卫生研究院文献>American Journal of Human Genetics >PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum Genotype-Phenotype Correlation and Phenotypic Heterogeneity
【2h】

PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum Genotype-Phenotype Correlation and Phenotypic Heterogeneity

机译:PTPN11突变的Noonan综合征:分子光谱基因型-表型相关性和表型异质性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Noonan syndrome (NS) is a developmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal malformations. We recently demonstrated that mutations in PTPN11, the gene encoding the non–receptor-type protein tyrosine phosphatase SHP-2 (src homology region 2-domain phosphatase–2), cause NS, accounting for ∼50% of cases of this genetically heterogeneous disorder in a small cohort. All mutations were missense changes and clustered at the interacting portions of the amino-terminal src-homology 2 (N-SH2) and protein tyrosine phosphatase (PTP) domains. A gain of function was postulated as a mechanism for the disease. Here, we report the spectrum and distribution of PTPN11 mutations in a large, well-characterized cohort with NS. Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS. There was a significantly higher prevalence of mutations among familial cases than among sporadic ones. All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains, but defects also affected residues in the C-SH2 domain, as well as in the peptide linking the N-SH2 and C-SH2 domains. Genotype-phenotype analysis revealed that pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01), whereas hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P<.005). The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups. A PTPN11 mutation was identified in a family inheriting Noonan-like/multiple giant-cell lesion syndrome, extending the phenotypic range of disease associated with this gene.
机译:Noonan综合征(NS)是一种发育障碍,特征是面部畸形,身材矮小,心脏缺损和骨骼畸形。我们最近证明,编码非受体型蛋白酪氨酸磷酸酶SHP-2(src同源区域2域磷酸酶-2)的基因PTPN11中的突变会引起NS,约占这种遗传异质性疾病病例的50%在一个小的队列中。所有突变都是错义变化,并聚集在氨基末端src-homology 2(N-SH2)和蛋白酪氨酸磷酸酶(PTP)域的相互作用部分。推测功能增加是该疾病的机制。在这里,我们报告了一个大型,特征明确的NS人群中PTPN11突变的光谱和分布。在119名不相关的散发或家族性NS患者中,有54名(占45%)发现突变。家族性病例的突变发生率比散发性病例高得多。所有缺陷都是错义的,有一些是经常性的。绝大多数突变改变了位于N-SH2和PTP结构域相互作用表面内或周围的氨基酸残基,但缺陷也影响了C-SH2结构域以及连接N-SH2和C的肽段中的残基-SH2域。基因型-表型分析显示,肺部狭窄在患有PTPN11突变的NS受试者组中比没有他们的组更为普遍(70.6%对46.2%; P <.01),而肥厚型心肌病的发生率较低PTPN11突变的患者中(5.9%vs. 26.2%; P <.005)。两组之间其他先天性心脏畸形,身材矮小,眼睑畸形,隐睾和发育迟缓的患病率无差异。 PTPN11突变被发现在一个继承了Noonan样/多巨细胞病变综合征的家族中,扩展了与此基因有关的疾病的表型范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号